News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Dec 26, 2008

  Insmed to Appeal Delisting Notification From Nasdaq
• Dec 23, 2008

  Insmed Announces that NASDAQ Extends Temporary Suspension of Minimum Bid Closing Price Rule
• Nov 25, 2008

  Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
• Nov 18, 2008

  Insmed to Participate in Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for Competition and Continued Innovation
• Nov 10, 2008

  Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
• Nov 5, 2008

  Insmed to Present at Upcoming Healthcare Conferences
• 
  Oct 30, 2008

  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008

  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008

  • Photos 4
• Oct 22, 2008

  NASDAQ's Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmed's Compliance Date to March 20, 2009
• Oct 21, 2008

  Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
• Oct 20, 2008

  Insmed to Host Third Quarter 2008 Conference Call

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download